Figure 4. Effect of 3ETH on growth of BxPc3 human pancreatic cancer xenografts in NOD/SCID mice.
Two million BxPc3 cells were subcutaneously injected, and drug treatment was started at day 4. 3ETH was injected intraperitoneally three times a week for 4 weeks. Tumors were harvested and weights were measured. Top panel: tumors; Bottom panel: weights.